NO995723L - Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer - Google Patents

Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer

Info

Publication number
NO995723L
NO995723L NO995723A NO995723A NO995723L NO 995723 L NO995723 L NO 995723L NO 995723 A NO995723 A NO 995723A NO 995723 A NO995723 A NO 995723A NO 995723 L NO995723 L NO 995723L
Authority
NO
Norway
Prior art keywords
treatment
autoimmune diseases
derivatives useful
triptolide derivatives
new
Prior art date
Application number
NO995723A
Other languages
English (en)
Norwegian (no)
Other versions
NO995723D0 (no
Inventor
Michel Jean Jung
Mahinda Wickramaratne
Michael Hepperle
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO995723D0 publication Critical patent/NO995723D0/no
Publication of NO995723L publication Critical patent/NO995723L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995723A 1997-05-23 1999-11-22 Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer NO995723L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86248897A 1997-05-23 1997-05-23
PCT/US1998/008470 WO1998052951A1 (en) 1997-05-23 1998-04-27 Novel triptolide derivatives useful in the treatment of autoimmune diseases

Publications (2)

Publication Number Publication Date
NO995723D0 NO995723D0 (no) 1999-11-22
NO995723L true NO995723L (no) 2000-01-21

Family

ID=25338616

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995723A NO995723L (no) 1997-05-23 1999-11-22 Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer

Country Status (20)

Country Link
EP (1) EP0983275B1 (de)
JP (1) JP2001525851A (de)
KR (1) KR20010012822A (de)
CN (1) CN1257507A (de)
AR (1) AR012723A1 (de)
AT (1) ATE222910T1 (de)
AU (1) AU741917B2 (de)
BR (1) BR9809678A (de)
CA (1) CA2287977A1 (de)
DE (1) DE69807466T2 (de)
DK (1) DK0983275T3 (de)
ES (1) ES2178207T3 (de)
HU (1) HUP0003398A3 (de)
IL (1) IL133088A0 (de)
NO (1) NO995723L (de)
NZ (1) NZ500762A (de)
PT (1) PT983275E (de)
TW (1) TW434235B (de)
WO (1) WO1998052951A1 (de)
ZA (1) ZA984174B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329148B1 (en) 1999-02-16 2001-12-11 The Board Of Trustees Of The Leland Stanford University Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells
EP1390358A4 (de) * 2001-03-15 2004-06-16 Pharmagenesis Inc Aminosäurederivate von triptolidverbindungen als immunmodulatoren und antikrebsmittel
AU2003243351B2 (en) 2002-05-31 2009-04-30 Pharmagenesis, Inc. Triptolide derivatives for modulation of apoptosis and immunosuppression
CN100398544C (zh) * 2002-09-18 2008-07-02 成都达远药物有限公司 高免疫抑制活性的水溶性雷公藤内酯醇衍生物及其应用
WO2004058246A1 (en) * 2002-12-17 2004-07-15 Pharmagenesis, Inc. Triptolide derivatives as immunomodulator and anticancer agents
CN1223595C (zh) * 2002-12-27 2005-10-19 中国科学院上海药物研究所 雷公藤内酯醇衍生物及其应用
US6943259B2 (en) * 2003-02-25 2005-09-13 Pharmagenesis, Inc. Halogenated triptolide derivatives as immunomodulators and anticancer agents
US7820834B2 (en) 2003-12-24 2010-10-26 Pharmagenesis, Inc. Triptolide 5,6-derivatives as immunomodulators and anticancer agents
WO2005077008A2 (en) 2004-02-09 2005-08-25 Pharmagenesis, Inc. Methods for isolation of triptolide compounds from tripterygium wilfordii
ES2385716T3 (es) 2004-03-02 2012-07-30 Pharmagenesis, Inc. Derivados en el anillo de lactona de triptolida como inmunomoduladores y agentes anticáncer
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis
US8617906B2 (en) 2004-10-13 2013-12-31 Pharmagenesis, Inc. Identification and screening of triptolide target molecules
JP5653939B2 (ja) * 2009-02-05 2015-01-14 ファーマジェネシス， インコーポレイテッド 抗癌剤および免疫調節因子としてのトリプトリドｃ環誘導体
KR102452412B1 (ko) * 2015-10-29 2022-10-06 항조우 웨벤 파마슈티컬스 인크 트리프톨리드의 c14-히드록실 에스테르화 아미노산 유도체, 및 그의 제조 방법 및 용도
CN114716503B (zh) * 2022-03-23 2024-03-12 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） 一种雷公藤氯内酯醇的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005108A (en) * 1973-04-03 1977-01-25 Research Corporation Novel anti-leukemic diterpenoid triepoxides
US5430054A (en) * 1989-12-22 1995-07-04 Jiangsu Family Planning Institute Preparation methods of diterpene lactone compounds and application of the same to antifertility
US5663335A (en) * 1996-03-01 1997-09-02 Pharmagenesis, Inc. Immunosuppressive compounds and methods

Also Published As

Publication number Publication date
TW434235B (en) 2001-05-16
CA2287977A1 (en) 1998-11-26
PT983275E (pt) 2003-01-31
ATE222910T1 (de) 2002-09-15
AU741917B2 (en) 2001-12-13
ZA984174B (en) 1998-11-23
NZ500762A (en) 2001-08-31
KR20010012822A (ko) 2001-02-26
IL133088A0 (en) 2001-03-19
EP0983275B1 (de) 2002-08-28
HUP0003398A3 (en) 2001-09-28
DE69807466T2 (de) 2003-04-24
HUP0003398A2 (en) 2001-03-28
WO1998052951A1 (en) 1998-11-26
AU7260798A (en) 1998-12-11
JP2001525851A (ja) 2001-12-11
BR9809678A (pt) 2000-07-11
DK0983275T3 (da) 2002-12-23
NO995723D0 (no) 1999-11-22
CN1257507A (zh) 2000-06-21
DE69807466D1 (de) 2002-10-02
ES2178207T3 (es) 2002-12-16
AR012723A1 (es) 2000-11-08
HK1026096A1 (en) 2000-12-01
EP0983275A1 (de) 2000-03-08

Similar Documents

Publication Publication Date Title
EE04190B1 (et) Asendatud bensopüraani derivaatide kasutamine põletiku raviks
FI973292A7 (fi) Substituoituja isoksatsoleja tulehduksen hoitamiseksi
NO991955D0 (no) FremgangsmÕte for behandling av hydrokarboner
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
NO994256D0 (no) SmÕ molekyler som er anvendelige ved behandling av inflamasjonssykdom
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO995095L (no) Substituerte imidazoler nyttig ved behandlingen av inflammasjonssykdommer
FI962141A0 (fi) Rytmihäiriöitä vastustavat bentsodiatsepiinit
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
NO995221D0 (no) Sulfonamider for behandling av endotelinmedierte sykdommer
NO995723D0 (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
NO973178D0 (no) Indol-derivater anvendelige ved behandling av osteporose
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
NO995722L (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
FI971527A7 (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
TR199800068A3 (tr) Benzofenon türevlerinin hazirlanmasina yönelik metodlar.
NO993549L (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
NO306402B1 (no) 3-arylalkenyl-1,2,4-oksadiazolderivater og deres anvendelse, samt mellomprodukter for oppnaaelse av derivatene
NO986053L (no) Anticonvulsivt virkende derivater for anvendelse ved behandling av psoriasis
NO930436L (no) Fremgangsmåte ved fremstilling av baderom

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application